7 KILLED, HUNDREDS INJURED AS STRONG QUAKE HITS SULAWESI, INDONESIA
VATICAN: POPE FRANCIS, FORMER POPE BENEDICT BOTH GET COVID-19 VACCINE
AUSTRALIA REBUKES GOOGLE FOR BLOCKING LOCAL CONTENT
JAPAN TO BAN ENTRY OF FOREIGN ATHLETES TO TRAIN AHEAD OF SUMMER OLYMPICS
BIDEN INAUGURATION WILL FEATURE DIVERSE PERFORMANCES INCLUDING LADY GAGA, JENNIFER LOPEZ
COURT ORDERS ARREST OF COPS ACCUSED OF KILLING ARMY MEN IN JOLO
THE PANDEMIC SLAMS PHL VEHICLE SALES IN 2020
CHESS PLAYER WESLEY SO BAGS P11.8M, JOINS WORLD’S TOP ESPORT EARNERS
ZSA ZSA PADILLA FINALLY VISITS THE GRAVE OF ‘COMEDY KING’ DOLPHY AGAIN
DUTERTE: PRESIDENCY JOB NOT FOR A WOMEN

ASTRAZENECA DEAL OFF IF VACCINE FAILS TO GET FDA APPROVAL

5 months ago | Nation | 0 comments

By Xai Reyes

Department of Health (DOH) secretary Francisco Duque III said the COVID-19 vaccine deal among the government , the private sector and AstraZeneca may be voided if the British drugmaker’s vaccine fails to get regulatory approval in the Philippines.

Duque emphasized that the tripartite agreement requires the candidate vaccine to undergo evaluation by vaccine experts and the Food and Drug Administration (FDA).

Asked whether the agreement will be voided if the vaccine fails DFA standards, Duque said: “Posible ‘yan, syempre dahil ibig sabihin may violation ng agreement.”

Health Undersecretary Maria Rosario Vergeire said the supply deal, secured by the private sector, was an “advanced commitment” to ensure the Philippines will get 2.6 million shots of the vaccine.

AstraZeneca’s vaccine, which is reportedly 70% effective against COVID-19 at its first half dose and 90% after the second full dose, is up for evaluation by the Philippine Vaccine Experts Panel and the Ethics Review Board.

0 Comments

Submit a Comment

Your email address will not be published.

Social Media